Predicting the subcutaneous (SC) bioavailability of biologics and monoclonal antibodies remains challenging due to the complex interplay between formulation and physiological factors.
This webinar will provide an overview of emerging New Approach Methodologies (NAMs) for SC drug development, including ECM diffusion models such as SCISSOR™, microfluidic skin-on-a-chip platforms, and PBPK modeling.
Discover how these complementary in vitro and in silico approaches can improve understanding of SC drug behavior, support biopredictive in vitro–in vivo translation, and help de-risk development.
Presenter:
Manuel Sanchez-Felix
Principal & Founder
Sanchez-Felix Drug Delivery Consulting
